Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
Journal of Virology|November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral ReservoirsDiane L Bolton, Amarendra Pegu, Keyun Wang, et al.
Nature Communications|February 15, 2019
Improvement of antibody functionality by structure-guided paratope engraftmentQingbo Liu, Yen-Ting Lai, Peng Zhang, et al.
Journal for Immunotherapy of Cancer|October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumorsElizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Dermatology and Therapy|February 11, 2026
Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD RegistryLi Zhang, Naihui Zhou, Zhouwei Wu, et al.
Journal of Virology|May 26, 2017
Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus MonkeysBoris Julg, Amarendra Pegu, Peter Abbink, et al.
Journal of Virology|March 20, 2015
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus InfectionKevin O Saunders, Amarendra Pegu, Ivelin S Georgiev, et al.
European Radiology|August 13, 2025
Noninvasive evaluation of treatment-related protein expression status in advanced gastric cancer using dynamic nomograms with dual-energy CT: a multicenter studyYiyang Liu, Yaru You, Lihong Chen, et al.
Microbiology Spectrum|November 3, 2021
Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020Pan Fu, Hongmei Xu, Chunmei Jing, et al.
Nature Communications|October 21, 2015
Activation and lysis of human CD4 cells latently infected with HIV-1Amarendra Pegu, Mangaiarkarasi Asokan, Lan Wu, et al.
Plos Pathogens|March 27, 2019
Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodiesCelia C LaBranche, Andrew T McGuire, Matthew D Gray, et al.
Pageof 32